Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

The Lancet Oncology, ‎1470-2045

Journal

  1. 2022
  2. Published

    Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

    participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research, Aug 2022, In: The Lancet Oncology. 23, 8, p. e374-e384

    Research output: Contribution to journalReviewpeer-review

  3. Published

    Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

    Kater, A. P., Levin, M-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., van der Kevie-Kersemaekers, A-M. F., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Brieghel, C., Mattsson, M., Bellido, M., Tran, H. T. T. & 2 others, Nasserinejad, K. & Niemann, C. U., Jun 2022, In: The Lancet Oncology. 23, 6, p. 818-828 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  4. Published

    KRASG12C inhibition in colorectal cancer

    Pfeiffer, P. & Qvortrup, C., Jan 2022, In: The Lancet Oncology. 23, 1, p. 10-11 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  5. Published

    Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial

    Mauz-Körholz, C., Landman-Parker, J., Balwierz, W., Ammann, R. A., Anderson, R. A., Attarbaschi, A., Bartelt, J. M., Beishuizen, A., Boudjemaa, S., Cepelova, M., Claviez, A., Daw, S., Dieckmann, K., Fernández-Teijeiro, A., Fosså, A., Gattenlöhner, S., Georgi, T., Hjalgrim, L. L., Hraskova, A., Karlén, J. & 15 others, Kluge, R., Kurch, L., Leblanc, T., Mann, G., Montravers, F., Pears, J., Pelz, T., Rajić, V., Ramsay, A. D., Stoevesandt, D., Uyttebroeck, A., Vordermark, D., Körholz, D., Hasenclever, D. & Wallace, W. H., Jan 2022, In: The Lancet Oncology. 23, 1, p. 125-137 13 p.

    Research output: Contribution to journalJournal articlepeer-review

  6. Published

    Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

    Smith, M. R., Scher, H. I., Sandhu, S., Efstathiou, E., Lara, P. N., Yu, E. Y., George, D. J., Chi, K. N., Saad, F., Ståhl, O., Olmos, D., Danila, D. C., Mason, G. E., Espina, B. M., Zhao, X., Urtishak, K. A., Francis, P., Lopez-Gitlitz, A., Fizazi, K., GALAHAD investigators & 1 others, Brasso, K., 2022, In: The Lancet Oncology. 23, 3, p. 362-373 12 p.

    Research output: Contribution to journalJournal articlepeer-review

  7. 2021
  8. Published

    Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

    COVIDSurg Collaborative, Ebbehøj, A. L., Krarup, P-M., Schlesinger, N. H. & Smith, H. G., Nov 2021, In: The Lancet Oncology. 22, 11, p. 1507-1517 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  9. Published

    Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Early Breast Cancer Trialists’ Collaborative group (EBCTCG) & Ejlertsen, B., Aug 2021, In: The Lancet Oncology. 22, 8, p. 1139-1150 12 p.

    Research output: Contribution to journalJournal articlepeer-review

  10. Published

    Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study

    Cardoso, R., Guo, F., Heisser, T., Hackl, M., Ihle, P., De Schutter, H., Van Damme, N., Valerianova, Z., Atanasov, T., Májek, O., Mužík, J., Nilbert, M. C., Tybjerg, A. J., Innos, K., Mägi, M., Malila, N., Bouvier, A-M., Bouvier, V., Launoy, G., Woronoff, A-S. & 36 others, Cariou, M., Robaszkiewicz, M., Delafosse, P., Poncet, F., Katalinic, A., Walsh, P. M., Senore, C., Rosso, S., Vincerževskienė, I., Lemmens, V. E. P. P., Elferink, M. A. G., Johannesen, T. B., Kørner, H., Pfeffer, F., Bento, M. J., Rodrigues, J., Alves da Costa, F., Miranda, A., Zadnik, V., Žagar, T., Lopez de Munain Marques, A., Marcos-Gragera, R., Puigdemont, M., Galceran, J., Carulla, M., Chirlaque, M-D., Ballesta, M., Sundquist, K., Sundquist, J., Weber, M., Jordan, A., Herrmann, C., Mousavi, M., Ryzhov, A., Hoffmeister, M. & Brenner, H., Jul 2021, In: The Lancet Oncology. 22, 7, p. 1002-1013 12 p.

    Research output: Contribution to journalJournal articlepeer-review

  11. Published

    Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

    International Mismatch Repair Consortium, Gerdes, A-M. A. & van Overeem Hansen, T., Jul 2021, In: The Lancet Oncology. 22, 7, p. 1014-1022 9 p.

    Research output: Contribution to journalJournal articlepeer-review

  12. Published

    Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply

    Grønberg, B. H., Langer, S. W., Nyman, J. & Halvorsen, T. O., Jun 2021, In: The Lancet Oncology. 22, 6, p. e222

    Research output: Contribution to journalComment/debatepeer-review

  13. Published

    Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

    MACH-NC and MARCH Collaborative Groups & Kristensen, C. A., May 2021, In: The Lancet Oncology. 22, 5, p. 727-736 10 p.

    Research output: Contribution to journalJournal articlepeer-review

  14. Published

    Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

    innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators, May 2021, In: The Lancet Oncology. 22, 5, p. 609-619 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  15. Published

    Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial

    Andre, T., Amonkar, M., Norquist, J. M., Shiu, K. K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C. J. A., Smith, D., Garcia-Carbonero, R., Sevilla, I., De La Fouchardiere, C., Rivera, F., Elez, E., Diaz, L. A., Yoshino, T., Van Cutsem, E., Yang, P., Farooqui, M. & Le, D. T., May 2021, In: The Lancet Oncology. 22, 5, p. 665-677 13 p.

    Research output: Contribution to journalJournal articlepeer-review

  16. Published

    High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

    Grønberg, B. H., Killingberg, K. T., Fløtten, Ø., Brustugun, O. T., Hornslien, K., Madebo, T., Langer, S. W., Schytte, T., Nyman, J., Risum, S., Tsakonas, G., Engleson, J. & Halvorsen, T. O., Mar 2021, In: The Lancet Oncology. 22, 3, p. 321-331 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  17. 2020
  18. Published

    Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    Powles, T., van der Heijden, M. S., Castellano, D., Galsky, M. D., Loriot, Y., Petrylak, D. P., Ogawa, O., Park, S. H., Lee, J-L., De Giorgi, U., Bögemann, M., Bamias, A., Eigl, B. J., Gurney, H., Mukherjee, S. D., Fradet, Y., Skoneczna, I., Tsiatas, M., Novikov, A., Suárez, C. & 11 others, Fay, A. P., Duran, I., Necchi, A., Wildsmith, S., He, P., Angra, N., Gupta, A. K., Levin, W., Bellmunt, J., DANUBE study investigators & Pappot, H., Dec 2020, In: The Lancet Oncology. 21, 12, p. 1574-1588 15 p.

    Research output: Contribution to journalJournal articlepeer-review

  19. Published

    Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply

    Subbiah, V., Lassen, U., Gasal, E., Burgess, P. & Wainberg, Z. A., Nov 2020, In: Lancet Oncology. 21, 11, p. e516

    Research output: Contribution to journalComment/debatepeer-review

  20. Published

    Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

    Subbiah, V., Lassen, U., Élez, E., Italiano, A., Curigliano, G., Javle, M., de Braud, F., Prager, G. W., Greil, R., Stein, A., Fasolo, A., Schellens, J. H. M., Wen, P. Y., Viele, K., Boran, A. D., Gasal, E., Burgess, P., Ilankumaran, P. & Wainberg, Z. A., Sep 2020, In: The Lancet Oncology. 21, 9, p. 1234-1243 10 p.

    Research output: Contribution to journalJournal articlepeer-review

  21. Published

    Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

    Al-Sawaf, O., Zhang, C., Tandon, M., Sinha, A., Fink, A-M., Robrecht, S., Samoylova, O., Liberati, A. M., Pinilla-Ibarz, J., Opat, S., Sivcheva, L., Le Dû, K., Fogliatto, L. M., Niemann, C. U., Weinkove, R., Robinson, S., Kipps, T. J., Tausch, E., Schary, W., Ritgen, M. & 6 others, Wendtner, C-M., Kreuzer, K-A., Eichhorst, B., Stilgenbauer, S., Hallek, M. & Fischer, K., Sep 2020, In: The Lancet Oncology. 21, 9, p. 1188-1200 13 p.

    Research output: Contribution to journalJournal articlepeer-review

  22. Published

    New approaches to cancer care in a COVID-19 world

    Butler, J., Finley, C., Norell, C. H., Harrison, S., Bryant, H., Achiam, M. P., Altman, A. D., Baxter, N., Bentley, J., Cohen, P. A., Chaudry, M. A., Dixon, E., Farrell, R., Fegan, S., Hashmi, S., Hogdall, C., Jenkins, J. T., Kwon, J., Mala, T., McNally, O. & 12 others, Merrett, N., Nelson, G., Nordin, A., Park, J., Porter, G., Reynolds, J., Schieman, C., Schnack, T., Spigelman, A., Svendsen, L. B., Sykes, P. & Thomas, R., Jul 2020, In: The Lancet Oncology. 21, 7, p. e339-e340

    Research output: Contribution to journalJournal articlepeer-review

  23. Published

    Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

    Lassen, U., Feb 2020, In: Lancet Oncology. 21, 2, p. 193-194 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  24. Published

    International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

    Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Devlin, N., Dorme, L., Flechtner, H-H., Gotay, C., Griebsch, I., Groenvold, M., King, M., Kluetz, P. G., Koller, M., Malone, D. C. & 15 others, Martinelli, F., Mitchell, S. A., Musoro, J. Z., O'Connor, D., Oliver, K., Piault-Louis, E., Piccart, M., Quinten, C., Reijneveld, J. C., Schürmann, C., Smith, A. W., Soltys, K. M., Taphoorn, M. J. B., Velikova, G. & Bottomley, A., Feb 2020, In: The Lancet Oncology. 21, 2, p. e83-e96 14 p.

    Research output: Contribution to journalReviewpeer-review

  25. 2019
  26. Published

    The incomplete story of complete mesocolic excision - Authors' reply

    Bertelsen, C. A., Neuenschwander, A. U. & Kleif, J., 1 Dec 2019, In: Lancet Oncology. 20, 12, p. e659

    Research output: Contribution to journalLetter

  27. Published

    Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review

    Mierzynska, J., Piccinin, C., Pe, M., Martinelli, F., Gotay, C., Coens, C., Mauer, M., Eggermont, A., Groenvold, M., Bjordal, K., Reijneveld, J., Velikova, G. & Bottomley, A., Dec 2019, In: Lancet Oncology. 20, 12, p. e685-e698 14 p.

    Research output: Contribution to journalReviewpeer-review

  28. Published
  29. Published

    Access to radiotherapy among circumpolar Inuit populations

    Chan, J., Friborg, J., Chernov, M., Cherkashin, M., Grau, C., Brundage, M. & Slotman, B., Oct 2019, In: Lancet Oncology. 20, 10, p. e590-e600

    Research output: Contribution to journalReviewpeer-review

  30. Published

    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

    AVANOVA investigators, Oct 2019, In: Lancet Oncology. 20, 10, p. 1409-1419 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  31. Published

    Combining PARP inhibition with PD-1 inhibitors

    Lassen, U., Sep 2019, In: Lancet Oncology. 20, 9, p. 1196-1198 3 p.

    Research output: Contribution to journalJournal articlepeer-review

  32. Published

    Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, Jun 2019, In: Lancet Oncology. 20, 6, p. 862-876 15 p.

    Research output: Contribution to journalJournal articlepeer-review

  33. Published

    Meta-analysis of penile cancer: conceptual interpretations - Authors' reply

    Albieri, V., Olesen, T. B., Sand, F. L., Rasmussen, C. L., Toft, B. G., Norrild, B., Munk, C. & Kjær, S. K., Mar 2019, In: Lancet Oncology. 20, 3, p. e126

    Research output: Contribution to journalComment/debatepeer-review

  34. Published

    Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial

    de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J-P., Arkenau, H-T., Plummer, R., Jones, R. H., Nielsen, D., Windfeld, K., Ghatta, S., Slomovitz, B. M., Spicer, J. F., Yachnin, J., Ang, J. E., Mau-Sørensen, P. M., Forster, M. D., Collins, D., Dean, E., Rangwala, R. A. & 1 others, Lassen, U., Mar 2019, In: Lancet Oncology. 20, 3, p. 383-393 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  35. Published

    A European paediatric cancer mission: aspiration or reality?

    Kearns, P. R., Vassal, G., Ladenstein, R., Schrappe, M., Biondi, A., Blanc, P., Eggert, A., Kienesberger, A., Kozhaeva, O., Pieters, R. & Schmiegelow, K., 2019, In: Lancet Oncology. 20, 9, p. 1200-1202 3 p.

    Research output: Contribution to journalComment/debatepeer-review

  36. Published

    Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis

    Olesen, T. B., Sand, F. L., Rasmussen, C. L., Albieri, V., Toft, B. G., Norrild, B., Munk, C. & Kjær, S. K., 2019, In: Lancet Oncology. 20, 1, p. 145-158 14 p.

    Research output: Contribution to journalJournal articlepeer-review

  37. Published

    Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial

    Oscarsson, N., Müller, B., Rosén, A., Lodding, P., Mölne, J., Giglio, D., Hjelle, K. M., Vaagbø, G., Hyldegaard, O., Vangedal, M., Salling, L., Kjellberg, A., Lind, F., Ettala, O., Arola, O. & Seeman-Lodding, H., 2019, In: Lancet Oncology. 20, 11, p. 1602-1614 13 p.

    Research output: Contribution to journalJournal articlepeer-review

  38. Published

    Solid organ transplantations in childhood cancer survivors: an unrealised research potential

    Winther, J. F., Schmidt, I. M. & Poggio, E. D., 2019, In: Lancet Oncology. 20, 10, p. 1337-1338 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  39. 2018
  40. Published

    Maternal use of hormonal contraception and risk of childhood leukaemia - Authors' reply

    Hargreave, M., Mørch, L. S., Andersen, K. K., Winther, J. F., Schmiegelow, K. & Kjaer, S. K., Dec 2018, In: Lancet Oncology. 19, 12, p. e659

    Research output: Contribution to journalComment/debatepeer-review

  41. Published

    Integration of oncology and palliative care: a Lancet Oncology Commission

    Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E., Brunelli, C., Caraceni, A., Cervantes, A., Currow, D. C., Deliens, L., Fallon, M., Gómez-Batiste, X., Grotmol, K. S., Hannon, B., Haugen, D. F., Higginson, I. J., Hjermstad, M. J., Hui, D., Jordan, K. & 10 others, Kurita, G. P., Larkin, P. J., Miccinesi, G., Nauck, F., Pribakovic, R., Rodin, G., Sjøgren, P., Stone, P., Zimmermann, C. & Lundeby, T., Nov 2018, In: Lancet Oncology. 19, 11, p. e588-e653

    Research output: Contribution to journalReviewpeer-review

  42. Published

    Maternal use of hormonal contraception and risk of childhood leukaemia: a nationwide, population-based cohort study

    Hargreave, M., Mørch, L. S., Andersen, K. K., Winther, J. F., Schmiegelow, K. & Kjaer, S. K., Oct 2018, In: Lancet Oncology. 19, 10, p. 1307-1314 8 p.

    Research output: Contribution to journalJournal articlepeer-review

  43. Published

    CCR4-targeted therapy in cutaneous T-cell lymphoma

    Gniadecki, R., Sep 2018, In: Lancet Oncology. 19, 9, p. 1140-1141 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  44. Published

    Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review

    Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium (SISAQOL), Sep 2018, In: Lancet Oncology. 19, 9, p. e459-e469 11 p.

    Research output: Contribution to journalReviewpeer-review

  45. Published

    Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

    Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., Aug 2018, In: Lancet Oncology. 19, 8, p. 1117-1125 9 p.

    Research output: Contribution to journalJournal articlepeer-review

  46. Published

    Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

    Waszak, S. M., Northcott, P. A., Buchhalter, I., Robinson, G. W., Sutter, C., Groebner, S., Grund, K. B., Brugières, L., Jones, D. T. W., Pajtler, K. W., Morrissy, A. S., Kool, M., Sturm, D., Chavez, L., Ernst, A., Brabetz, S., Hain, M., Zichner, T., Segura-Wang, M., Weischenfeldt, J. & 67 others, Rausch, T., Mardin, B. R., Zhou, X., Baciu, C., Lawerenz, C., Chan, J. A., Varlet, P., Guerrini-Rousseau, L., Fults, D. W., Grajkowska, W., Hauser, P., Jabado, N., Ra, Y-S., Zitterbart, K., Shringarpure, S. S., De La Vega, F. M., Bustamante, C. D., Ng, H-K., Perry, A., MacDonald, T. J., Hernáiz Driever, P., Bendel, A. E., Bowers, D. C., McCowage, G., Chintagumpala, M. M., Cohn, R., Hassall, T., Fleischhack, G., Eggen, T., Wesenberg, F., Feychting, M., Lannering, B., Schüz, J., Johansen, C., Andersen, T. V., Röösli, M., Kuehni, C. E., Grotzer, M., Kjaerheim, K., Monoranu, C. M., Archer, T. C., Duke, E., Pomeroy, S. L., Shelagh, R., Frank, S., Sumerauer, D., Scheurlen, W., Ryzhova, M. V., Milde, T., Kratz, C. P., Samuel, D., Zhang, J., Solomon, D. A., Marra, M., Eils, R., Bartram, C. R., von Hoff, K., Rutkowski, S., Ramaswamy, V., Gilbertson, R. J., Korshunov, A., Taylor, M. D., Lichter, P., Malkin, D., Gajjar, A., Korbel, J. O. & Pfister, S. M., 1 Jun 2018, In: Lancet Oncology. 19, 6, p. 785-798

    Research output: Contribution to journalJournal articlepeer-review

  47. Published

    Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

    Colleoni, M., Luo, W., Karlsson, P., Chirgwin, J., Aebi, S., Jerusalem, G., Neven, P., Hitre, E., Graas, M-P., Simoncini, E., Kamby, C., Thompson, A., Loibl, S., Gavilá, J., Kuroi, K., Marth, C., Müller, B., O'Reilly, S., Di Lauro, V., Gombos, A. & 13 others, Ruhstaller, T., Burstein, H., Ribi, K., Bernhard, J., Viale, G., Maibach, R., Rabaglio-Poretti, M., Gelber, R. D., Coates, A. S., Di Leo, A., Regan, M. M., Goldhirsch, A. & SOLE Investigators, 2018, In: Lancet Oncology. 19, 1, p. 127-138

    Research output: Contribution to journalJournal articlepeer-review

  48. Published

    Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database

    Brok, J., Lopez-Yurda, M., Tinteren, H. V., Treger, T. D., Furtwängler, R., Graf, N., Bergeron, C., van den Heuvel-Eibrink, M. M., Pritchard-Jones, K., Olsen, Ø. E., de Camargo, B., Verschuur, A. & Spreafico, F., 2018, In: Lancet Oncology. 19, 8, p. 1072-1081 10 p.

    Research output: Contribution to journalJournal articlepeer-review

  49. 2017
  50. Published

    European position statement on lung cancer screening

    Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., Baldwin, D. R., Callister, M. E., Becker, N., Heuvelmans, M. A., Rzyman, W., Infante, M. V., Pastorino, U., Pedersen, J. H., Paci, E., Duffy, S. W. & 2 others, de Koning, H. & Field, J. K., Dec 2017, In: Lancet Oncology. 18, 12, p. e754-e766

    Research output: Contribution to journalReviewpeer-review

  51. Published

    Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study

    Wolthers, B. O., Frandsen, T. L., Baruchel, A., Attarbaschi, A., Barzilai, S., Colombini, A., Escherich, G., Grell, K., Inaba, H., Kovacs, G., Liang, D-C., Mateos, M., Mondelaers, V., Möricke, A., Ociepa, T., Samarasinghe, S., Silverman, L. B., van der Sluis, I. M., Stanulla, M., Vrooman, L. M. & 4 others, Yano, M., Zapotocka, E., Schmiegelow, K. & Ponte di Legno Toxicity Working Group, Sep 2017, In: Lancet Oncology. 18, 9, p. 1238-1248 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  52. Published

    Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

    Tap, W. D., Papai, Z., Van Tine, B. A., Attia, S., Ganjoo, K. N., Jones, R. L., Schuetze, S., Reed, D., Chawla, S. P., Riedel, R. F., Krarup-Hansen, A., Toulmonde, M., Ray-Coquard, I., Hohenberger, P., Grignani, G., Cranmer, L. D., Okuno, S., Agulnik, M., Read, W., Ryan, C. W. & 8 others, Alcindor, T., Del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P., Aug 2017, In: Lancet Oncology. 18, 8, p. 1089-1103 15 p.

    Research output: Contribution to journalJournal articlepeer-review

  53. Published

    Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? - Authors' reply

    Schmiegelow, K., Nielsen, S. N. & Grell, K., Jun 2017, In: Lancet Oncology. 18, 6, p. e292

    Research output: Contribution to journalJournal articlepeer-review

  54. Published

    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

    Ascierto, P. A., Del Vecchio, M., Robert, C., Mackiewicz, A., Chiarion-Sileni, V., Arance, A., Lebbé, C., Bastholt, L., Hamid, O., Rutkowski, P., McNeil, C., Garbe, C., Loquai, C., Dreno, B., Thomas, L., Grob, J-J., Liszkay, G., Nyakas, M., Gutzmer, R., Pikiel, J. & 10 others, Grange, F., Hoeller, C., Ferraresi, V., Smylie, M., Schadendorf, D., Mortier, L., Svane, I. M., Hennicken, D., Qureshi, A. & Maio, M., May 2017, In: Lancet Oncology. 18, 5, p. 611-622 12 p.

    Research output: Contribution to journalJournal articlepeer-review

Previous 1 2 Next

ID: 109280